Caxton Associates »

Sage Therapeutics shares owned by Caxton Associates

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Caxton Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 120k 21.67
2023-09-30 $1.4M 68k 20.58
2022-06-30 $595k 18k 32.29
2021-12-31 $747k 18k 42.56
2021-09-30 $503k 11k 44.28